《大行報告》高盛將中海宏洋(00081.HK)剔出確信名單 維持「買入」評級
高盛發表報告指,自從今年1月15日將中海宏洋(00081.HK)評級上調至「買入」及加入確信名單後,其股價下跌了11%,對比同期MSCI中國指數為上升18%,主要由於行業處於下行周期,且政府因去槓桿而收緊政策,導致板塊普遍不受投資者青睞。
該行相信,雖然集團各方面的基本面都穩固,但其市值小及交投流動性萎縮,導致股價低迷。另外,高盛認為市場太聚焦於中海宏洋在行業下行時所有業務都處低線城市,而忽略了其在中海外等支持下未來的增長前景,且集團的擴展基數仍低。
由於較不利的市場定位,高盛將中海宏洋剔出確信名單,不過維持其「買入」評級,目標價6.6元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.